276 related articles for article (PubMed ID: 21600753)
1. Estimating national-level syringe availability to injecting drug users and injection coverage: Switzerland, 1996-2006.
Arnaud S; Jeannin A; Dubois-Arber F
Int J Drug Policy; 2011 May; 22(3):226-32. PubMed ID: 21600753
[TBL] [Abstract][Full Text] [Related]
2. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
Emmanuel F; Fatima M
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
[TBL] [Abstract][Full Text] [Related]
3. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
[TBL] [Abstract][Full Text] [Related]
4. Performance and coverage of HIV interventions for injection drug users: Insights from triangulation of programme, field and surveillance data from Pakistan.
Khan AA; Khan A
Int J Drug Policy; 2011 May; 22(3):219-25. PubMed ID: 21530216
[TBL] [Abstract][Full Text] [Related]
5. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates.
Barrio G; Bravo MJ; Brugal MT; Díez M; Regidor E; Belza MJ; de la Fuente L;
Addiction; 2012 Jun; 107(6):1111-22. PubMed ID: 22151686
[TBL] [Abstract][Full Text] [Related]
6. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.
Wodak A; Cooney A
Subst Use Misuse; 2006; 41(6-7):777-813. PubMed ID: 16809167
[TBL] [Abstract][Full Text] [Related]
7. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
Sarang A; Rhodes T; Platt L
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
[TBL] [Abstract][Full Text] [Related]
9. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
Razali SM
Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
[TBL] [Abstract][Full Text] [Related]
10. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
Amundsen EJ
Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
[No Abstract] [Full Text] [Related]
11. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.
Bluthenthal RN; Ridgeway G; Schell T; Anderson R; Flynn NM; Kral AH
Addiction; 2007 Apr; 102(4):638-46. PubMed ID: 17286637
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
Takács IG; Demetrovics Z
Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
[TBL] [Abstract][Full Text] [Related]
14. Thinking ethically about needle and syringe programs.
Kleinig J
Subst Use Misuse; 2006; 41(6-7):815-25. PubMed ID: 16809168
[TBL] [Abstract][Full Text] [Related]
15. Heroin-assisted treatment in Switzerland: a case study in policy change.
Uchtenhagen A
Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
[TBL] [Abstract][Full Text] [Related]
16. Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.
Irwin K; Karchevsky E; Heimer R; Badrieva L
Subst Use Misuse; 2006; 41(6-7):979-99. PubMed ID: 16809182
[TBL] [Abstract][Full Text] [Related]
17. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.
Maher L; Iversen J; Kaldor J
Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184
[No Abstract] [Full Text] [Related]
18. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
Panda S; Sharma M
Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
[TBL] [Abstract][Full Text] [Related]
19. Syringe prescription for injection drug users to prevent disease.
J Assoc Nurses AIDS Care; 2012; 23(3):275-6. PubMed ID: 22645745
[No Abstract] [Full Text] [Related]
20. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
